Citi Pharma schedules board meeting for October 30, 2026

Board Meeting

Citi Pharma Limited will hold a board meeting on October 30, 2026, to consider and approve its unaudited unconsolidated and consolidated condensed interim financial statements for the quarter ended September 30, 2026. A closed period applies from October 24 through October 30, 2026, inclusive.

Key Findings

  • Board meeting scheduled for October 30, 2026, at 4:00 p.m. at the company’s head office in Lahore.
  • The board will consider interim financial statements for the quarter ended September 30, 2026.
  • The closed period runs from October 24 to October 30, 2026, inclusive; directors, the CEO, and executives are prohibited from dealing in company shares during this period.

Meeting Details

Meeting time
30/10/2026, 4:00 PM
Agenda
Financial results
Financial Period
Quarter ended September 30, 2026
Location
Head office, 588, Q-Block, Johar Town, Lahore
Closed period from
24/10/2026
Closed period to
30/10/2026
⚡

Highlights summarize the key points from the company's official PSX filing. View the original filing for the complete details before making financial decisions.

More CPHL announcements

Built for PSX investors

Every filing.Summarised.

Key findings from every PSX announcement, right beside live prices and your portfolio.

Investify company announcements with result figures and filing highlights
Investify announcement summary with key findings from a PSX filing